News | December 17, 2023
Briefs: Torrent Pharmaceuticals and Laurus Synthesis
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Laurus Synthesis receives Form 483 with 5 observations from USFDA
Research released at UN General Assembly week shows tests predicting heart disease and diabetes are among lowest cost solutions for improving Indian health
The return profile of NCDs is linked to BBL share price subject to minimum IRR of 12%.
Apollo continues to invest in genomics technology and research for better patient care
Krishna Institute of Medical Sciences to consider raising Rs. 300 crores
The company will submit an action plan on the observations and will engage with US FDA for next steps.
As per 10th edition of International Diabetes Federation (IDF) Atlas, 2021, India has 74.2 million people with diabetes between the age of 20-79 years
LHWRF will work with the State’s Department of Health and Family Welfare for strengthening the healthcare system and addressing the prevalence of CVD and COPD for better outcomes
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
This partnership aims to embed latest technological advancements in diagnosing and managing lung disorders and associated non-communicable diseases like asthma, pulmonary fibrosis and COPD.
Subscribe To Our Newsletter & Stay Updated
